Abstract
Background Vaccination has significantly contributed to reducing once common and even deadly infectious diseases, yet vaccine hesitancy threatens the emergence of vaccine-preventable diseases. The COVID-19 pandemic has caused the need for the largest mass vaccination campaign ever undertaken to date; however, African, Caribbean, and Black (ACB) populations have shown both a disproportionately high degree of negative impacts from the pandemic and the lowest willingness to become vaccinated. Low vaccination rates in this vulnerable population are a pinnacle concern in public health, as low vaccination rates in ACB communities may both be the result of health inequities, as well as further exacerbate them.
Purpose To explore low vaccine uptake in African, Caribbean, and Black (ACB) populations relative to public health in high-income countries. Objectives 1) To identify concepts and boundaries of existing evidence sources on low vaccine uptake in ACB populations; 2) To map out the evidence on the concepts and boundaries and to identify gaps in the research; and 3) To determine existing interventions to improve low vaccine uptake in the study population.
Methodology This scoping review follows the Joanna Briggs Institute (JBI) framework for scoping reviews, supplemented by the Preferred Reporting Items for Systematic Reviews extension (PRISMA-ScR). Any deviations from the JBI recommendations are stated. Theoretical underpinnings of the intersectionality approach will be used to help interpret the complexities of health inequities in the ACB population, including those related to the social determinants of health (SDOH). Search strategies were developed by an information specialist (VC) and peer- reviewed using the PRESS guideline. The search was conducted in: MEDLINE(R) ALL (OvidSP), Embase (OvidSP), CINAHL (EBSCOHost), APA PsycInfo (OvidSP), Cochrane Central Register of Controlled Trials (OvidSP), Cochrane Database of Systematic Reviews (OvidSP), Allied & Complimentary Medicine Database (Ovid SP), and Web of Science. Eligibility criteria are based on the Population, Concept, Context (PCC) framework. The inclusion criteria for this study included evidence -sources with a primary focus on African, Caribbean, and Black populations, and other related terms; high-income countries as defined by the World Bank where ACB populations are considered a minority; all service providers; English and French languages; all types of evidence sources; related to low vaccine uptake and alternative terms; all vaccines; and publications from 2020- current (July 19th, 2022). The screening, selection, and extraction of the evidence sources were completed by the AVA research team. Analysis was done through the process of Thematic Mapping, and summarization and presentation of the findings were done through a narrative description organized using the socioeconomic model (SEM) as a framework.
Ethics and dissemination This study used published evidence sources with no human or animal participants; thus, ethical approval and consent to participate are not applicable.
Dissemination This will occur through peer-reviewed open-access journals and conferences that target stakeholders in public health, vaccination campaigns and overcoming inequities in healthcare.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Ottawa Research Ethics Board (REB). Please see protocol code: H-12-21-7558, approved on 26/02/2022
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
